# Atlanticus Holdings Corp: financial statements, quarterly

ATLC · Nasdaq · CIK 1464343 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/atlc.md) · [Financials](/companies/atlc/financials.md) · [Filings](/companies/atlc/filings.md) · [Insiders](/companies/atlc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/atlc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [295](/filings/0001437749-24-033997.md) | [309 d](/filings/0001437749-25-007559.md) | [291](/filings/0001437749-25-015559.md) | [316](/filings/0001437749-25-025502.md) | [351](/filings/0001437749-25-033947.md) | [353 d](/filings/0001437749-26-007972.md) | [345](/filings/0001437749-26-015592.md) | [394](/filings/0001437749-26-026279.md) | [495](/filings/0001437749-25-033947.md) | [734 d](/filings/0001437749-26-007972.md) | [680](/filings/0001437749-26-015592.md) | [744](/filings/0001437749-26-026279.md) |
| Cost of revenue | $m | [25.9](/filings/0001437749-24-033997.md) | [26.6 d](/filings/0001437749-25-007559.md) | [26.8](/filings/0001437749-25-015559.md) | [27.7](/filings/0001437749-25-025502.md) | [28.1](/filings/0001437749-25-033947.md) | [35.8 d](/filings/0001437749-26-007972.md) | [32.2](/filings/0001437749-26-015592.md) | [34.1](/filings/0001437749-26-026279.md) | [39.0](/filings/0001437749-25-033947.md) | [55.6 d](/filings/0001437749-26-007972.md) | [44.9](/filings/0001437749-26-015592.md) | [57.9](/filings/0001437749-26-026279.md) |
| Interest expense | $m | [28.3](/filings/0001437749-24-033997.md) | [32.6 d](/filings/0001437749-25-007559.md) | [35.1](/filings/0001437749-25-015559.md) | [37.9](/filings/0001437749-25-025502.md) | [42.5](/filings/0001437749-25-033947.md) | [44.7 d](/filings/0001437749-26-007972.md) | [47.5](/filings/0001437749-26-015592.md) | [53.7](/filings/0001437749-26-026279.md) | [75.5](/filings/0001437749-25-033947.md) | [125 d](/filings/0001437749-26-007972.md) | [123](/filings/0001437749-26-015592.md) | [123](/filings/0001437749-26-026279.md) |
| Income tax | $m | [6.8](/filings/0001437749-24-033997.md) | [4.4 d](/filings/0001437749-25-007559.md) | [7.0](/filings/0001437749-25-015559.md) | [4.5](/filings/0001437749-25-025502.md) | [8.1](/filings/0001437749-25-033947.md) | [8.9 d](/filings/0001437749-26-007972.md) | [9.7](/filings/0001437749-26-015592.md) | [9.9](/filings/0001437749-26-026279.md) | [7.9](/filings/0001437749-25-033947.md) | [11.6 d](/filings/0001437749-26-007972.md) | [14.3](/filings/0001437749-26-015592.md) | [16.3](/filings/0001437749-26-026279.md) |
| Net income | $m | [25.2](/filings/0001437749-24-033997.md) | [26.3 d](/filings/0001437749-25-007559.md) | [26.2](/filings/0001437749-25-015559.md) | [24.3](/filings/0001437749-25-025502.md) | [29.5](/filings/0001437749-25-033947.md) | [31.3 d](/filings/0001437749-26-007972.md) | [31.5](/filings/0001437749-26-015592.md) | [30.6](/filings/0001437749-26-026279.md) | [25.0](/filings/0001437749-25-033947.md) | [35.1 d](/filings/0001437749-26-007972.md) | [44.2](/filings/0001437749-26-015592.md) | [49.7](/filings/0001437749-26-026279.md) |
| Diluted EPS | $ per share | [1.03](/filings/0001437749-24-033997.md) | not reported | [1.09](/filings/0001437749-25-015559.md) | [0.99](/filings/0001437749-25-025502.md) | [1.27](/filings/0001437749-25-033947.md) | not reported | [1.49](/filings/0001437749-26-015592.md) | [1.51](/filings/0001437749-26-026279.md) | [1.21](/filings/0001437749-25-033947.md) | not reported | [2.23](/filings/0001437749-26-015592.md) | [2.50](/filings/0001437749-26-026279.md) |
| Basic EPS | $ per share | [1.30](/filings/0001437749-24-033997.md) | not reported | [1.35](/filings/0001437749-25-015559.md) | [1.22](/filings/0001437749-25-025502.md) | [1.58](/filings/0001437749-25-033947.md) | not reported | [1.85](/filings/0001437749-26-015592.md) | [1.87](/filings/0001437749-26-026279.md) | [1.50](/filings/0001437749-25-033947.md) | not reported | [2.80](/filings/0001437749-26-015592.md) | [3.13](/filings/0001437749-26-026279.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [356](/filings/0001437749-24-033997.md) | [339](/filings/0001437749-25-007559.md) | [445](/filings/0001437749-25-015559.md) | [351](/filings/0001437749-25-025502.md) | [309](/filings/0001437749-25-033947.md) | [375](/filings/0001437749-26-007972.md) | [350](/filings/0001437749-26-015592.md) | [329](/filings/0001437749-26-026279.md) | [425](/filings/0001437749-25-033947.md) | [621](/filings/0001437749-26-026279.md) | [651](/filings/0001437749-26-015592.md) | [555](/filings/0001437749-26-026279.md) |
| Total assets | $m | [2,597](/filings/0001437749-24-033997.md) | [2,706](/filings/0001437749-25-007559.md) | [2,787](/filings/0001437749-25-015559.md) | [2,837](/filings/0001437749-25-025502.md) | [3,040](/filings/0001437749-25-033947.md) | [3,271](/filings/0001437749-26-007972.md) | [3,272](/filings/0001437749-26-015592.md) | [3,643](/filings/0001437749-26-026279.md) | [7,080](/filings/0001437749-25-033947.md) | [7,623](/filings/0001437749-26-026279.md) | [7,465](/filings/0001437749-26-015592.md) | [7,492](/filings/0001437749-26-026279.md) |
| Total liabilities | $m | [2,082](/filings/0001437749-23-031049.md) | [2,174](/filings/0001437749-25-007559.md) | [2,234](/filings/0001437749-24-016032.md) | [2,266](/filings/0001437749-24-025592.md) | [2,471](/filings/0001437749-24-033997.md) | [2,691](/filings/0001437749-26-007972.md) | [2,703](/filings/0001437749-25-015559.md) | [3,044](/filings/0001437749-25-025502.md) | [6,455](/filings/0001437749-25-033947.md) | [6,979](/filings/0001437749-26-026279.md) | [6,781](/filings/0001437749-26-015592.md) | [6,754](/filings/0001437749-26-026279.md) |
| Shareholders' equity | $m | [377](/filings/0001437749-23-031049.md) | [395](/filings/0001437749-25-007559.md) | [416](/filings/0001437749-24-016032.md) | [434](/filings/0001437749-24-025592.md) | [458](/filings/0001437749-24-033997.md) | [493](/filings/0001437749-26-007972.md) | [533](/filings/0001437749-25-015559.md) | [563](/filings/0001437749-25-025502.md) | [589](/filings/0001437749-25-033947.md) | [609](/filings/0001437749-26-026279.md) | [648](/filings/0001437749-26-015592.md) | [702](/filings/0001437749-26-026279.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [117 d](/filings/0001437749-24-033997.md) | [133 d](/filings/0001437749-25-007559.md) | [119](/filings/0001437749-25-015559.md) | [116 d](/filings/0001437749-25-025502.md) | [112 d](/filings/0001437749-25-033947.md) | [123 d](/filings/0001437749-26-007972.md) | [132](/filings/0001437749-26-015592.md) | [133 d](/filings/0001437749-26-026279.md) | [107 d](/filings/0001437749-25-033947.md) | [266 d](/filings/0001437749-26-007972.md) | [286](/filings/0001437749-26-015592.md) | [277 d](/filings/0001437749-26-026279.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [9.4 d](/filings/0001437749-24-033997.md) | [3.3 d](/filings/0001437749-25-007559.md) | [0.5](/filings/0001437749-25-015559.md) | [1.3 d](/filings/0001437749-25-025502.md) | [25.8 d](/filings/0001437749-25-033947.md) | [25.0 d](/filings/0001437749-26-007972.md) | [51.2](/filings/0001437749-26-015592.md) | [1.9 d](/filings/0001437749-26-026279.md) | [0.0 d](/filings/0001437749-25-033947.md) | [16.4 d](/filings/0001437749-26-007972.md) | [3.8](/filings/0001437749-26-015592.md) | [0.1 d](/filings/0001437749-26-026279.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [19.0](/filings/0001437749-23-031049.md) | [19.0](/filings/0001437749-24-016032.md) | [19.0](/filings/0001437749-24-025592.md) | [18.9](/filings/0001437749-24-033997.md) | [18.7](/filings/0001437749-25-015559.md) | [18.8](/filings/0001437749-25-025502.md) | [18.8](/filings/0001437749-25-033947.md) | [19.2](/filings/0001437749-26-015592.md) | [19.2](/filings/0001437749-26-026279.md) | [19.2](/filings/0001437749-25-033947.md) | [19.0](/filings/0001437749-26-015592.md) | [19.2](/filings/0001437749-26-026279.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 15,170,038 at 2026-08-01, from the cover of the [10-Q filed 2026-08-06](/filings/0001437749-26-026279.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.